A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder.
A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder.
复制标题
DOI:
10.1038/s41467-022-28318-4
复制
发表时间:
2022-02-04
影响因子:
16.6
通讯作者:
Baron J
中科院分区:
文献类型:
--
作者:
Lui JC;Raimann A;Hojo H;Dong L;Roschger P;Kikani B;Wintergerst U;Fratzl-Zelman N;Jee YH;Haeusler G;Baron J
SP7/Osterix is a transcription factor critical for osteoblast maturation and bone formation. Homozygous loss-of-function mutations in SP7 cause osteogenesis imperfecta type XII, but neomorphic (gain-of-new-function) mutations of SP7 have not been reported in humans. Here we describe a de novo dominant neomorphic missense variant (c.926 C > G:p.S309W) in SP7 in a patient with craniosynostosis, cranial hyperostosis, and long bone fragility. Histomorphometry shows increased osteoblasts but decreased bone mineralization. Mice with the corresponding variant also show a complex skeletal phenotype distinct from that of Sp7-null mice. The mutation alters the binding specificity of SP7 from AT-rich motifs to a GC-consensus sequence (typical of other SP family members) and produces an aberrant gene expression profile, including increased expression of Col1a1 and endogenous Sp7, but decreased expression of genes involved in matrix mineralization. Our study identifies a pathogenic mechanism in which a mutation in a transcription factor shifts DNA binding specificity and provides important in vivo evidence that the affinity of SP7 for AT-rich motifs, unique among SP proteins, is critical for normal osteoblast differentiation. SP7 is a transcription factor required for osteoblast differentiation and bone formation. A neomorphic mutation in SP7 was found to alter DNA binding specificity, causing a complex skeletal disorder in both mice and humans.
DOI:
10.1016/j.bbrc.2012.03.073
发表时间:
2012-04-20
影响因子:
3.1
作者:
Zhang C;Dai H;de Crombrugghe B
通讯作者:
de Crombrugghe B